The EGF receptor provides an essential survival signal for SOS-dependent skin tumor development

被引:260
作者
Sibilia, M
Fleischmann, A
Behrens, A
Stingl, L
Carroll, J
Watt, FM
Schlessinger, J
Wagner, EF
机构
[1] Res Inst Mol Pathol, A-1030 Vienna, Austria
[2] Imperial Canc Res Fund, London WC2A 3PX, England
[3] NYU Med Ctr, Dept Pharmacol, New York, NY 10016 USA
基金
奥地利科学基金会;
关键词
D O I
10.1016/S0092-8674(00)00026-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The EGF receptor (EGFR) is required for skin development and is implicated in epithelial tumor formation. Transgenic mice expressing a dominant form of Son of Sevenless (SOS-F) in basal keratinocytes develop skin papillomas with 100% penetrance. However, tumor formation is inhibited in a hypomorphic (wa2) and null EGFR background. Similarly, EGFR-deficient fibroblasts are resistant to transformation by SOS-F and rasV12, however, tumorigenicity is restored by expression of the anti-apoptotic bcl-2 gene. The K5-SOS-F papillomas and primary keratinocytes from wa2 mice display increased apoptosis, reduced Akt phosphorylation and grafting experiments imply a cell-autonomous requirement for EGFR in keratinocytes. Therefore, EGFR functions as a survival factor in oncogenic transformation and provides a valuable target for therapeutic intervention in a broader range of tumors than anticipated.
引用
收藏
页码:211 / 220
页数:10
相关论文
共 51 条
[31]   RAPID INDUCTION OF HEPARIN-BINDING EPIDERMAL GROWTH-FACTOR DIPHTHERIA-TOXIN RECEPTOR EXPRESSION BY RAF AND RAS ONCOGENES [J].
MCCARTHY, SA ;
SAMUELS, ML ;
PRITCHARD, CA ;
ABRAHAM, JA ;
MCMAHON, M .
GENES & DEVELOPMENT, 1995, 9 (16) :1953-1964
[32]   EPITHELIAL IMMATURITY AND MULTIORGAN FAILURE IN MICE LACKING EPIDERMAL GROWTH-FACTOR RECEPTOR [J].
MIETTINEN, PJ ;
BERGER, JE ;
MENESES, J ;
PHUNG, Y ;
PEDERSEN, RA ;
WERB, Z ;
DERYNCK, R .
NATURE, 1995, 376 (6538) :337-341
[33]   EXPRESSION OF A DOMINANT-NEGATIVE MUTANT OF EPIDERMAL GROWTH-FACTOR RECEPTOR IN THE EPIDERMIS OF TRANSGENIC MICE ELICITS STRIKING ALTERATIONS IN HAIR FOLLICLE DEVELOPMENT AND SKIN-STRUCTURE [J].
MURILLAS, R ;
LARCHER, F ;
CONTI, CJ ;
SANTOS, M ;
ULLRICH, A ;
JORCANO, JL .
EMBO JOURNAL, 1995, 14 (21) :5216-5223
[34]   Drug resistance of human glioblastoma cells conferred by a tumor-specific mutant epidermal growth factor receptor through modulation of Bcl-XL and caspase-3-like proteases [J].
Nagane, M ;
Levitzki, A ;
Gazit, A ;
Cavenee, WK ;
Huang, HJS .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1998, 95 (10) :5724-5729
[35]  
PRIGENT S A, 1992, Progress in Growth Factor Research, V4, P1, DOI 10.1016/0955-2235(92)90002-Y
[36]  
RAMIREZ A, 1994, DIFFERENTIATION, V58, P53, DOI 10.1007/s002580050065
[37]   ANTI-ONCOGENIC ACTIVITY OF SIGNALING-DEFECTIVE EPIDERMAL GROWTH-FACTOR RECEPTOR MUTANTS [J].
REDEMANN, N ;
HOLZMANN, B ;
VONRUDEN, T ;
WAGNER, EF ;
SCHLESSINGER, J ;
ULLRICH, A .
MOLECULAR AND CELLULAR BIOLOGY, 1992, 12 (02) :491-498
[38]  
REICHMANN E, 1994, SEMIN CANCER BIOL, V5, P157
[39]   Regulation of Bcl-x(L) expression in human keratinocytes by cell-substratum adhesion and the epidermal growth factor receptor [J].
Rodeck, U ;
Jost, M ;
DuHadaway, J ;
Kari, C ;
Jensen, PJ ;
Risse, B ;
Ewert, DL .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (10) :5067-5072
[40]  
Rodeck U, 1997, J CELL SCI, V110, P113